Gan & Lee Pharmaceuticals. (SHA:603087)
63.51
-0.59 (-0.92%)
Nov 17, 2026, 3:00 PM CST
| Market Cap | 37.81B -5.5% |
| Revenue (ttm) | 4.37B +13.7% |
| Net Income | 1.18B +27.8% |
| EPS | 2.00 +27.1% |
| Shares Out | 595.33M |
| PE Ratio | 31.75 |
| Forward PE | 21.75 |
| Dividend | 1.00 (1.58%) |
| Ex-Dividend Date | May 29, 2026 |
| Volume | 4,410,918 |
| Open | 63.78 |
| Previous Close | 64.10 |
| Day's Range | 63.13 - 64.65 |
| 52-Week Range | 51.51 - 79.99 |
| Beta | 0.34 |
| Analysts | Strong Buy |
| Price Target | 83.50 (+31.48%) |
| Earnings Date | Oct 28, 2026 |